Search Results 1531-1540 of 13397 for monoclonal antibody

  1. Remdesivir (intravenous route) - Side effects & uses - Mayo Clinic

    Brand Name. US Brand Name · Description. Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19) in hospitalized patients. · Before Using. In ...

  2. Lecanemab-irmb (intravenous route, subcutaneous route) - Side effects & uses - Mayo Clinic

    Lecanemab-irmb injection is used to treat Alzheimer's disease. This medicine is to be given only by or under the supervision of your doctor. This product is ...

  3. Mayo researchers correlate specific antibody with relapse of neurological disorder

    ... antibody, myelin oligodendrocyte glycoprotein — also known as MOG, and an increased risk of recurring attacks in these individuals. Mayo Clinic neurologists ...

  4. A Study To Evaluate CC-98633 To Treat Subjects With Relapsed And/or Refractory Multiple Myeloma - Mayo Clinic

    ... monoclonal protein, skin changes) syndrome, or clinically significant amyloidosis. ... antibodies or molecules, antibody-drug conjugates (BCMA-ADC), or ...

  5. Mayo Clinic launches neutralizing antibody test to advance COVID-19 therapies

    The neutralizing antibody test provides semi-quantitative detection of total neutralizing antibodies against the SARS-CoV-2 spike glycoprotein in human serum.

  6. Presatovir In Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection Of The Upper Respiratory Tract - Mayo Clinic

    Documented to be RSV-positive as determined by local testing (eg, polymerase chain reaction, direct fluorescence antibody ... monoclonal anti-RSV antibodies ...

  7. Presatovir In Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection Of The Lower Respiratory Tract - Mayo Clinic

    Use of non-marketed (according to region) investigational agents within 30 days, OR use of any monoclonal anti-RSV antibodies within 4 months or 5 half ...

  8. COVID-19 Antibody Testing Clinical Trials - Mayo Clinic Research

    ... antibody detectable targets on cancer cells (cancer vaccines or antibody guided therapeutics). In this approach, we isolate and affinity-column immobilize ...

  9. A Study To Evaluate The Efficacy And Safety Of Belantamab Mafodotin In Combination With Cyclophosphamide, Bortezomib, And Dexamethasone In Adult Participants With Newly Diagnosed Amyloid Light Chain Amyloidosis - Mayo Clinic

    Evidence of a monoclonal plasma cell proliferative disorder (serum or urine monoclonal protein, abnormal free light chain ratio, or clonal plasma cells in the ...

  10. Study Of EO-3021 In Adult Patients With Solid Tumors Likely To Express CLDN18.2 - Mayo Clinic

    infusion reaction or hypersensitivity (CTCAE Grade 3 or higher) with monoclonal antibody treatment - Clinically significant cardiac disease, including but ...